CascaDTx - Shaping the Future of Digital Cancer Care.

In Development, Built with the End in Mind

CascaDTx is currently under development as an AI-elevated next-generation digital therapeutic (DTx) platform for oncology. From the start, our design follows global principles for safety, clinical evidence, and patient privacy, ensuring a pathway toward regulatory acceptance and real-world impact. 

Our Difference - A Therapy-First Approach to Digital Therapeutics

While other digital health solutions focus on monitoring or general wellness, we are developing CascaDTx including these capabilities :

Therapy-first

Cancer care tools designed around oncology treatment, not just symptom monitoring.

Oncology-focused

Built specifically for cancer care, including pathways for chemo, radio, and radioligand therapy.

Patient & Family-centric

We include patients, family and caregivers as part of our care journey.

Trusted Evidence

Developed under DTx principles for safety, impact, clinical validation, and regulatory readiness.

Our Vision for Patients & Families

We are building CascaDTx to deliver:

  • Side effect support – tools to help patients manage fatigue, pain, and nausea.

  • Treatment adherence – reminders and trackers to keep patients on therapy.

  • Emotional well-being resources – evidence-based support for anxiety, depression, and sleep.

  • Family engagement – caregiver tools to strengthen support networks.

We are in an exciting transition phase: early design and development are underway, and we are preparing to build the first full prototypes. CascadTx is looking for partners, clinicians, and investors who share our vision to complete the platform and bring its benefits to patients and healthcare systems worldwide.

Empowering Clinicians & Health Systems

Our goal is to equip clinicians with actionable insights from patient-reported outcomes and help health systems:

Prevent adverse events.

Reduce treatment interruptions.

Lower overall healthcare costs.

Generate real-world evidence to inform care and value-based reimbursement

Built on Principles from Day One, CascaDTx is being developed to align with international DTx standards:

  • Patient safety first (no harm, quality by design)

  • Evidence-based development (clinical trials + peer-reviewed publication)

  • Privacy & security (HIPAA, GDPR, PIPEDA alignment)

  • Regulatory readiness (SaMD and PDT pathways)